Home / Healthcare / Mobile Medical Screening Market

Mobile Medical Screening Market Size, Share & Industry Analysis, By Test Type (Single Test Panels, Multi Test Panels), By Sample Type (Blood, Saliva, Urine, Others), By Collection Site (Home Care Settings, Others) and Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI103135 | Status : Upcoming

Mobile medical screening is a secure mobile health platform designed for users to receive their laboratory results and manage their personal health information directly from their smartphones. Through this platform, people are given the access to monitor their health and take routine health check ups without personally visiting any medical facilities. The platform allows people to directly take a look at their medical reports through their smart phones or any other digital technology. The concept of mobile medical screening is a perfect example of incorporating of digital technologies to enhance treatment procedures. Factors such as rising importance of healthy life expectancy coupled with growing government focus towards preventive healthcare have significanlty augmented mobile medical screening market growth. Moreover, growing prevalence of chronic disorders such as diabetes and cardiovascular diseases are expected to drive the growth of this market.


Increasing prevalence of chronic ailments such as cardiovascular diseases, diabetes, and several others is one of the major factors propelling mobile medical screening market growth across the forecast period. For instance, as per Centers for Disease Control and Prevention, coronary heart disease is the most common form of cardiovascular disorder in the U.S. In 2017, about 18.2 million people above the age of 20 had chronic heart disorders, which is around 6.7% of the total U.S. population. Such factors are estimated to support the growth of the market. Also, increasing R&D activities pertaining to digital health services coupled with rising government funding for the initiation of such projects are further anticipated to boost mobile medical screening market across the projection period.



However, dearth of awareness among the population of developing economies pertaining to the benefits of mobile medical screening platforms is also impeding the growth of the market.


Market Segmentation:


Globally, the mobile medical screening market can be classified on the basis of test type, sample type, collection site, and region. Based on the test type, the market can be segmented into single test panels and multi test panels. Based on the sample type, the market can be segmented into blood, saliva, urine and others. Based on the collection site the market can be segmented into homecare settings and others.


Geographically, the mobile medical screening market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the mobile medical screening market are Telomere Diagnostics, Quest Diagnostics, Genova Diagnostics, Life Length, Repeat Diagnostics, Zimetry LLC, Titanovo, Inc., DNA Labs, Cleveland HeartLab, Inc. and other prominent players.


Key Insights:



  • Technological Advancements by Key Countries/Region

  • Introduction of New Products/Approvals (By Major Players)

  • Key Industry Developments Mergers, Acquisitions, and Collaborations

  • Industry Background of Mobile Medical Screening


Regional Analysis:


Geographically, the mobile medical screening market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North American region is likely to hold the largest share of the market and is anticipated to follow the same impetus over the forecast period. This growth of the market can be attributed to the presence of refined healthcare infrastructure along with growing awareness regarding physical and health related issues. Moreover, increase in the prevalence of chronic ailments such as diabetes, obesity, heart disorders and few others coupled with availability & high adoption of technologically advanced products are also driving the market in this region. Europe is projected to be the second most productive market throughout the forecast period. The factors such as adoption of innovative digital health services and rise in geriatric population in this region are likely to boost the growth of the mobile medical screening market in this region. However, Asia-Pacific is likely to expand at high growth rate in near future. The growth of the market can be attributed to the increase in the elderly population, presence of large patient pool suffering from chronic ailments, and rise in the disposable income of the population. The market in Latin America and the Middle East and Africa are expected to grow moderately in the forecast period.



Segmentation


























 ATTRIBUTE


  DETAILS

By Test Type




  • Single Test Panels

  • Multi Test Panels



By Sample Type




  • Blood

  • Saliva

  • Urine

  • Others



By Collection Site




  • Home Care Settings

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Mobile Medical Screenings Market Industry Developments



  • In January 2016, Telomere Diagnostics launched TeloYears, a new telomere test in its medical screening platform. Such novel initiatives assisted the company to expand its customer base.  

  • In September 2016, Life Length, world leader in telomere testing announced the partnership with Eastern Biotech to distribute its telomere platform in the GCC countries

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients